Gene therapy for pancreatic cancer—current and prospective strategies

This publication has 85 references indexed in Scilit:

• Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo
  Gene Therapy, 2001
• Retroviral vectors
  Molecular Pathology, 2000
• Direct Immunologic activities of CpG DNA and implications for gene therapy
  The Journal of Gene Medicine, 1999
• A chimeric fusion protein containing transforming growth factor-α mediates gene transfer via binding to the EGF receptor
  Gene Therapy, 1998
• p16^INK4 Expression Is Associated with the Increased Sensitivity of Human Non‐small Cell Lung Cancer Cells to DNA Topoisomerase I Inhibitors
  Japanese Journal of Cancer Research, 1997
• Suppression of Pancreatic Cancer by the Dominant NegativerasMutant, N116Y
  Journal of Surgical Research, 1996
• Antisense Regulation of Oncogenes in Human Cancer
  Critical Reviews™ in Oncogenesis, 1996
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
  Nature, 1993
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
  Cell, 1992
• Lymph node involvement in carcinoma of the head of the pancreas area
  Cancer, 1978